TDP43 Antibody - #AF6832
Product: | TDP43 Antibody |
Catalog: | AF6832 |
Description: | Rabbit polyclonal antibody to TDP43 |
Application: | WB IF/ICC |
Reactivity: | Human, Mouse, Rat |
Mol.Wt.: | 43kD; 45kD(Calculated). |
Uniprot: | Q13148 |
RRID: | AB_2847555 |
Product Info
*The optimal dilutions should be determined by the end user.
*Tips:
WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.
Cite Format: Affinity Biosciences Cat# AF6832, RRID:AB_2847555.
Fold/Unfold
ALS10; OTTHUMP00000002171; OTTHUMP00000002172; OTTHUMP00000002173; TADBP_HUMAN; TAR DNA binding protein 43; TAR DNA binding protein; TAR DNA-binding protein 43; TARDBP; TDP 43; TDP-43; TDP43;
Immunogens
A synthesized peptide derived from human TDP43.
Ubiquitously expressed. In particular, expression is high in pancreas, placenta, lung, genital tract and spleen.
- Q13148 TADBP_HUMAN:
- Protein BLAST With
- NCBI/
- ExPASy/
- Uniprot
MSEYIRVTEDENDEPIEIPSEDDGTVLLSTVTAQFPGACGLRYRNPVSQCMRGVRLVEGILHAPDAGWGNLVYVVNYPKDNKRKMDETDASSAVKVKRAVQKTSDLIVLGLPWKTTEQDLKEYFSTFGEVLMVQVKKDLKTGHSKGFGFVRFTEYETQVKVMSQRHMIDGRWCDCKLPNSKQSQDEPLRSRKVFVGRCTEDMTEDELREFFSQYGDVMDVFIPKPFRAFAFVTFADDQIAQSLCGEDLIIKGISVHISNAEPKHNSNRQLERSGRFGGNPGGFGNQGGFGNSRGGGAGLGNNQGSNMGGGMNFGAFSINPAMMAAAQAALQSSWGMMGMLASQQNQSGPSGNNQNQGNMQREPNQAFGSGNNSYSGSNSGAAIGWGSASNAGSGSGFNGGFGSSMDSKSSGWGM
PTMs - Q13148 As Substrate
Site | PTM Type | Enzyme | Source |
---|---|---|---|
S2 | Phosphorylation | P48729 (CSNK1A1) | Uniprot |
Y4 | Phosphorylation | P48729 (CSNK1A1) | Uniprot |
T25 | Phosphorylation | P48729 (CSNK1A1) | Uniprot |
S48 | Phosphorylation | Uniprot | |
K84 | Sumoylation | Uniprot | |
K84 | Ubiquitination | Uniprot | |
T88 | Phosphorylation | P48729 (CSNK1A1) | Uniprot |
S91 | Phosphorylation | P48729 (CSNK1A1) | Uniprot |
S92 | Phosphorylation | P48729 (CSNK1A1) | Uniprot |
K95 | Acetylation | Uniprot | |
K95 | Sumoylation | Uniprot | |
K95 | Ubiquitination | Uniprot | |
K102 | Sumoylation | Uniprot | |
K102 | Ubiquitination | Uniprot | |
K114 | Ubiquitination | Uniprot | |
T116 | Phosphorylation | P48729 (CSNK1A1) | Uniprot |
K121 | Sumoylation | Uniprot | |
K121 | Ubiquitination | Uniprot | |
K136 | Acetylation | Uniprot | |
K140 | Acetylation | Uniprot | |
K140 | Ubiquitination | Uniprot | |
K145 | Acetylation | Uniprot | |
K145 | Sumoylation | Uniprot | |
K145 | Ubiquitination | Uniprot | |
T153 | Phosphorylation | Uniprot | |
Y155 | Phosphorylation | Uniprot | |
K160 | Sumoylation | Uniprot | |
K160 | Ubiquitination | Uniprot | |
K176 | Sumoylation | Uniprot | |
K176 | Ubiquitination | Uniprot | |
K181 | Methylation | Uniprot | |
K181 | Sumoylation | Uniprot | |
K181 | Ubiquitination | Uniprot | |
S183 | Phosphorylation | P48729 (CSNK1A1) | Uniprot |
K192 | Acetylation | Uniprot | |
K192 | Sumoylation | Uniprot | |
K192 | Ubiquitination | Uniprot | |
K224 | Ubiquitination | Uniprot | |
S242 | Phosphorylation | P48729 (CSNK1A1) | Uniprot |
S254 | Phosphorylation | P48729 (CSNK1A1) | Uniprot |
K263 | Sumoylation | Uniprot | |
K263 | Ubiquitination | Uniprot | |
S273 | Phosphorylation | P48729 (CSNK1A1) | Uniprot |
R275 | Methylation | Uniprot | |
S292 | Phosphorylation | P48729 (CSNK1A1) | Uniprot |
R293 | Methylation | Uniprot | |
S305 | Phosphorylation | P48729 (CSNK1A1) | Uniprot |
S317 | Phosphorylation | Uniprot | |
S333 | Phosphorylation | Uniprot | |
S342 | Phosphorylation | P48729 (CSNK1A1) | Uniprot |
S347 | Phosphorylation | P48729 (CSNK1A1) | Uniprot |
S350 | Phosphorylation | P48729 (CSNK1A1) | Uniprot |
S369 | Phosphorylation | P48729 (CSNK1A1) | Uniprot |
S375 | Phosphorylation | P48729 (CSNK1A1) | Uniprot |
S377 | Phosphorylation | P48729 (CSNK1A1) | Uniprot |
S379 | Phosphorylation | P48729 (CSNK1A1) , P68400 (CSNK2A1) | Uniprot |
S387 | Phosphorylation | P48729 (CSNK1A1) | Uniprot |
S389 | Phosphorylation | P48729 (CSNK1A1) | Uniprot |
S393 | Phosphorylation | P48729 (CSNK1A1) | Uniprot |
S395 | Phosphorylation | P48729 (CSNK1A1) | Uniprot |
S403 | Phosphorylation | P48729 (CSNK1A1) | Uniprot |
S404 | Phosphorylation | P48729 (CSNK1A1) | Uniprot |
S407 | Phosphorylation | P48729 (CSNK1A1) | Uniprot |
K408 | Sumoylation | Uniprot | |
S409 | Phosphorylation | P68400 (CSNK2A1) , P48729 (CSNK1A1) | Uniprot |
S410 | Phosphorylation | P68400 (CSNK2A1) , P48729 (CSNK1A1) | Uniprot |
Research Backgrounds
RNA-binding protein that is involved in various steps of RNA biogenesis and processing. Preferentially binds, via its two RNA recognition motifs RRM1 and RRM2, to GU-repeats on RNA molecules predominantly localized within long introns and in the 3'UTR of mRNAs. In turn, regulates the splicing of many non-coding and protein-coding RNAs including proteins involved in neuronal survival, as well as mRNAs that encode proteins relevant for neurodegenerative diseases. Plays a role in maintaining mitochondrial homeostasis by regulating the processing of mitochondrial transcripts. Regulates also mRNA stability by recruiting CNOT7/CAF1 deadenylase on mRNA 3'UTR leading to poly(A) tail deadenylation and thus shortening. In response to oxidative insult, associates with stalled ribosomes localized to stress granules (SGs) and contributes to cell survival. Participates also in the normal skeletal muscle formation and regeneration, forming cytoplasmic myo-granules and binding mRNAs that encode sarcomeric proteins. Plays a role in the maintenance of the circadian clock periodicity via stabilization of the CRY1 and CRY2 proteins in a FBXL3-dependent manner.
Hyperphosphorylated in hippocampus, neocortex, and spinal cord from individuals affected with ALS and FTLDU. Phosphorylated upon cellular stress.
Ubiquitinated in hippocampus, neocortex, and spinal cord from individuals affected with ALS and FTLDU.
Cleaved to generate C-terminal fragments in hippocampus, neocortex, and spinal cord from individuals affected with ALS and FTLDU.
Nucleus. Cytoplasm. Cytoplasm>Stress granule.
Note: Continuously travels in and out of the nucleus (PubMed:18957508). Localizes to stress granules in response to oxidative stress (PubMed:19765185).
Ubiquitously expressed. In particular, expression is high in pancreas, placenta, lung, genital tract and spleen.
Homodimer. Homooligomer (via its N-terminal domain). Interacts with BRDT (By similarity). Binds specifically to pyrimidine-rich motifs of TAR DNA and to single stranded TG repeated sequences. Binds to RNA, specifically to UG repeated sequences with a minimun of six contiguous repeats. Interacts with ATNX2; the interaction is RNA-dependent. Interacts with MATR3. Interacts with UBQLN2. Interacts with HNRNPA2B1. Interacts with ZNF106 (By similarity). Interacts with CNOT7/CAF1. Interacts with CRY2.
Consists of an N-terminal domain (NTD) and two tandem RNA recognition motifs, RRM1 and RRM2, followed by a C-terminal glycine-rich region.
Contains a nuclear localization sequence and is mostly nuclear; however, its nuclear export sequence permits it to transport mRNAs to the cytoplasm and even to synapses as part of neuronal granules.
Restrictive clause
Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.
For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.